Cargando…

DNA damage response proteins in canine cancer as potential research targets in comparative oncology

The DNA damage response (DDR) is a complex signal transduction network that is activated when endogenous or exogenous genotoxins damage or interfere with the replication of genomic DNA. Under such conditions, the DDR promotes DNA repair and ensures accurate replication and division of the genome. Hi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hernández‐Suárez, Beatriz, Gillespie, David A., Pawlak, Aleksandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304296/ https://www.ncbi.nlm.nih.gov/pubmed/34923737 http://dx.doi.org/10.1111/vco.12795

Ejemplares similares

Studying the DNA damage response pathway in hematopoietic canine cancer cell lines, a necessary step for finding targets to generate new therapies to treat cancer in dogs
por: Hernández-Suárez, Beatriz, et al.
Publicado: (2023)

An initial characterisation of the Unfolded Protein Response pathway in haematopoietic canine cancer cell lines – a necessary step for the future development of new therapies in dogs with neoplasia
por: Hernández-Suárez, Beatriz, et al.
Publicado: (2023)

The Role of Bcl-xL Protein Research in Veterinary Oncology
por: Pawlak, Aleksandra, et al.
Publicado: (2020)

Chalcone Methoxy Derivatives Exhibit Antiproliferative and Proapoptotic Activity on Canine Lymphoma and Leukemia Cells
por: Pawlak, Aleksandra, et al.
Publicado: (2020)

Comparative mammary oncology: canine model
por: Cassali, Geovanni Dantas
Publicado: (2013)

Benzyl Isothiocyanate, a Vegetable-Derived Compound, Induces Apoptosis via ROS Accumulation and DNA Damage in Canine Lymphoma and Leukemia Cells
por: Henklewska, Marta, et al.
Publicado: (2021)

Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel
por: McDonald, J. Tyson, et al.
Publicado: (2018)

Emerging Translational Opportunities in Comparative Oncology With Companion Canine Cancers: Radiation Oncology
por: Nolan, Michael W., et al.
Publicado: (2019)

Correction: Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel
por: McDonald, J. Tyson, et al.
Publicado: (2018)

Pharmacological targeting of valosin containing protein (VCP) induces DNA damage and selectively kills canine lymphoma cells
por: Nadeau, Marie-Ève, et al.
Publicado: (2015)

Ubiquitin-Specific Proteases as Potential Therapeutic Targets in Bladder Cancer—In Vitro Evaluation of Degrasyn and PR-619 Activity Using Human and Canine Models
por: Nowak, Łukasz, et al.
Publicado: (2023)

Editorial: Canine melanoma in comparative oncology: Translate research advances to develop new diagnostic and therapeutic options
por: Bongiovanni, Laura, et al.
Publicado: (2023)

Ubiquitin‐specific protease 7 as a potential therapeutic target in dogs with hematopoietic malignancies
por: Pawlak, Aleksandra, et al.
Publicado: (2021)

Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology
por: Zimmer, Yitzhak, et al.
Publicado: (2020)

The Establishment of the Pfizer-Canine Comparative Oncology and Genomics Consortium Biospecimen Repository
por: Mazcko, Christina, et al.
Publicado: (2015)

Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms
por: Willmann, Michael, et al.
Publicado: (2018)

Editorial: Emerging Translational Opportunities in Comparative Oncology with Companion Canine Cancers
por: Dewhirst, Mark W., et al.
Publicado: (2020)

Canine osteosarcoma in comparative oncology: Molecular mechanisms through to treatment discovery
por: Simpson, Siobhan, et al.
Publicado: (2022)

Editorial: Canine osteosarcoma as a model in comparative oncology: Advances and perspective
por: Romanucci, Mariarita, et al.
Publicado: (2023)

Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint Inhibitors
por: Clark, Curtis A., et al.
Publicado: (2022)

Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials
por: Fazekas-Singer, Judit, et al.
Publicado: (2017)

Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting
por: Singer, Josef, et al.
Publicado: (2012)

Targeting K-Ras-mediated DNA damage response in radiation oncology: Current status, challenges and future perspectives
por: Toulany, Mahmoud
Publicado: (2022)

Cloning, localization and focus formation at DNA damage sites of canine XLF
por: KOIKE, Manabu, et al.
Publicado: (2016)

Targeting protein–protein interactions in the DNA damage response pathways for cancer chemotherapy
por: McPherson, Kerry Silva, et al.
Publicado: (2021)

Isolation and characterization of two canine melanoma cell lines: new models for comparative oncology
por: Segaoula, Zacharie, et al.
Publicado: (2018)

Cloning, localization and focus formation at DNA damage sites of canine XRCC4
por: KOIKE, Manabu, et al.
Publicado: (2016)

Cloning of canine Ku80 and its localization and accumulation at DNA damage sites
por: Koike, Manabu, et al.
Publicado: (2017)

Cloning, localization and focus formation at DNA damage sites of canine Ku70
por: KOIKE, Manabu, et al.
Publicado: (2017)

Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas
por: Hernandez, Belen, et al.
Publicado: (2018)

Potential interference of HTLV-1 HBZ protein with the DNA damage response pathway
por: Wurm, Torsten, et al.
Publicado: (2011)

Targeting DNA damage response in cancer therapy
por: Hosoya, Noriko, et al.
Publicado: (2014)

Therapeutic Targeting of DNA Damage Response in Cancer
por: Choi, Wonyoung, et al.
Publicado: (2022)

Targeting the DNA damage response for cancer therapy
por: Curtin, Nicola J.
Publicado: (2023)

Targeting the DNA Damage Response for Cancer Therapy
por: Wang, Ruoxi, et al.
Publicado: (2023)

Editorial: Mechanisms Underlying Diabetes-Associated Damage in Target Tissues
por: Suarez-Alvarez, Beatriz, et al.
Publicado: (2022)

Characteristics and Applications of Canine In Vitro Models of Bladder Cancer in Veterinary Medicine: An Up-to-Date Mini Review
por: Nowak, Łukasz, et al.
Publicado: (2022)

Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies
por: Padella, Antonella, et al.
Publicado: (2022)

A potential role for protein palmitoylation and zDHHC16 in DNA damage response
por: Cao, Na, et al.
Publicado: (2016)

The Effect of Xanthohumol Derivatives on Apoptosis Induction in Canine Lymphoma and Leukemia Cell Lines
por: Grudzień, Małgorzata, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5u0dcf7bk1rovo8if826vjjslb